Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-26

FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approved a generic version of griseofulvin (Ultramicrosize Griseofulvin) from Sandoz Inc under an Original Application (ANDA 202805) for dermatophyte infect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ULTRAMICROSIZE GRISEOFULVIN (griseofulvin)

Snippet

ORIG AP for ULTRAMICROSIZE GRISEOFULVIN (ULTRAMICROSIZE GRISEOFULVIN)